Andean Consulting Solutions International LLC (Acsi Translations), a certified 8(a) and small disadvantaged business, was awarded a $25 million single-award, indefinite delivery contract by the U.S. Food and Drug Administration (FDA) to provide national and international foreign language translation and interpretation services, both written and oral. This competitive contract runs from March 2023 through March 2028. Under this IDIQ, the FDA has issued multiple task orders to Acsi Translations to support various agency components, including the Center for Drug Evaluation and Research, Center for Tobacco Products, Office of Criminal Investigations, and Office of External Affairs, among others. The task orders, valued from $7,456 to $710,499, cover a range of language services such as translation, interpretation, transcription, and desktop publishing in over 80 languages. Acsi Translations also holds a $393,170 Army transcription services contract and a $1 million Multiple Award Schedule with GSA for federal agencies to procure language support as needed.
The scope of this FDA IDIQ contract and associated task orders is to provide cost-effective, multilingual language solutions that facilitate effective communication and support the agency's regulatory, enforcement, and public outreach activities across different centers and offices. As an experienced provider of language services to federal civilian agencies, Acsi Translations leverages its SBA 8(a) certification and small business capabilities to deliver high-quality translation, interpretation, and related services in a timely manner, furthering the FDA's mission.
Generated 9/7/24, 10:34 AM